Ϫ secretion in isolated crypt from rat distal colon did not identify Cl Ϫ -dependent HCO 3 Ϫ secretion but did reveal cAMPinduced, Cl Ϫ -independent HCO 3 Ϫ secretion. Studies were therefore initiated to determine the characteristics of HCO 3 Ϫ secretion in isolated colonic mucosa to identify HCO 3 Ϫ secretion in both surface and crypt cells. HCO 3 Ϫ secretion was measured in rat distal colonic mucosa stripped of muscular and serosal layers by using a pH stat technique. Basal HCO 3 Ϫ secretion (5.6 Ϯ 0.03 eq ⅐ h Ϫ1 ⅐ cm Ϫ2 ) was abolished by removal of either lumen Cl Ϫ or bath HCO 3 Ϫ ; this Cl Ϫ -dependent HCO 3 Ϫ secretion was also inhibited by 100 M DIDS (0.5 Ϯ 0.03 eq ⅐ h Ϫ1 ⅐ cm Ϫ2 ) but not by 5-nitro-3-(3-phenylpropylamino)benzoic acid (NPPB), a Cl Ϫ channel blocker. 8-Bromo-cAMP induced Cl Ϫ -independent HCO 3 Ϫ secretion (and also inhibited Cl Ϫ -dependent HCO 3 Ϫ secretion), which was inhibited by NPPB and by glibenclamide, a CFTR blocker, but not by DIDS. Isobutyrate, a poorly metabolized short-chain fatty acid (SCFA), also induced a Cl Ϫ -independent, DIDS-insensitive, saturable HCO 3 Ϫ secretion that was not inhibited by NPPB. Three distinct HCO 3 Ϫ secretory mechanisms were identified: 1) Cl Ϫ -dependent secretion associated with apical membrane Cl Ϫ /HCO 3 Ϫ exchange, 2) cAMP-induced secretion that was a result of an apical membrane anion channel, and 3)
secretion has long been recognized in the mammalian colon, but it has not been well characterized. Although most studies of colonic HCO 3 Ϫ secretion have revealed evidence of lumen Cl Ϫ dependence, suggesting a role for apical membrane Cl Ϫ /HCO 3 Ϫ exchange, direct examination of HCO 3 Ϫ secretion in isolated crypt from rat distal colon did not identify Cl Ϫ -dependent HCO 3 Ϫ secretion but did reveal cAMPinduced, Cl Ϫ -independent HCO 3 Ϫ secretion. Studies were therefore initiated to determine the characteristics of HCO 3 Ϫ secretion in isolated colonic mucosa to identify HCO 3 Ϫ secretion in both surface and crypt cells. HCO 3 Ϫ secretion was measured in rat distal colonic mucosa stripped of muscular and serosal layers by using a pH stat technique. Basal HCO 3 Ϫ secretion (5.6 Ϯ 0.03 eq ⅐ h Ϫ1 ⅐ cm Ϫ2 ) was abolished by removal of either lumen Cl Ϫ or bath HCO 3 Ϫ ; this Cl Ϫ -dependent HCO 3 Ϫ secretion was also inhibited by 100 M DIDS (0.5 Ϯ 0.03 eq ⅐ h Ϫ1 ⅐ cm Ϫ2 ) but not by 5-nitro-3-(3-phenylpropylamino)benzoic acid (NPPB), a Cl Ϫ channel blocker. 8-Bromo-cAMP induced Cl Ϫ -independent HCO 3 Ϫ secretion (and also inhibited Cl Ϫ -dependent HCO 3 Ϫ secretion), which was inhibited by NPPB and by glibenclamide, a CFTR blocker, but not by DIDS. Isobutyrate, a poorly metabolized short-chain fatty acid (SCFA), also induced a Cl Ϫ -independent, DIDS-insensitive, saturable HCO 3 Ϫ secretion that was not inhibited by NPPB. Three distinct HCO 3 Ϫ secretory mechanisms were identified: 1) Cl Ϫ -dependent secretion associated with apical membrane Cl Ϫ /HCO 3 Ϫ exchange, 2) cAMP-induced secretion that was a result of an apical membrane anion channel, and 3) SCFA-dependent secretion associated with an apical membrane SCFA/HCO 3 Ϫ exchange.
chloride/bicarbonate exchange; short-chain fatty acid/bicarbonate exchange; anion channel; pH stat THE MAMMALIAN COLON ABSORBS fluid, Na ϩ , and Cl Ϫ while secreting K ϩ and HCO 3 Ϫ (7). Although Na ϩ and Cl Ϫ absorption has been studied thoroughly during the past three decades (9) , the mechanism of colonic HCO 3 Ϫ secretion has not been investigated as extensively (14, 15, 17-20, 25, 38, 52) . The generally accepted model of basal HCO 3 Ϫ secretion has included an apical membrane Cl Ϫ /HCO 3 Ϫ exchange (17, 40) . Apical membrane Cl Ϫ /HCO 3 Ϫ exchanges also have been closely linked to Na ϩ /H ϩ exchange to account for electroneutral NaCl absorption (40, 42) , but they may also function independently of Na ϩ exchange are present in the apical membranes of surface cells of the distal colon, are not present in crypt cells, and are downregulated by cAMP and aldosterone (40 -42) .
In both clinical diarrhea and experimentally induced in vivo models of diarrhea, a HCO 3 Ϫ -rich, plasmalike solution has often been identified (21) . The driving force of fluid secretion in these models is active electrogenic Cl Ϫ secretion, which has been the subject of numerous in vitro investigations (1) . In contrast, HCO 3 Ϫ secretion that is induced by one or more secretogogues and second messengers has been studied less frequently and often is not observed in in vitro models. No adequate explanation has been proposed for the failure to observe HCO 3 Ϫ secretion in vitro despite its presence in in vivo models.
Spatial separation of surface cell and crypt cell function has been a long-standing concept of colonic physiology. Absorptive processes are present in surface cells, and secretory processes are present in crypt cells (63) . To study crypt cell function directly, we have developed methods for the isolation of 1) individual crypts that allow determination of fluid and electrolyte movement in crypts (25) and 2) apical membrane vesicles (AMV) from relatively pure crypt cell preparations that permit identification of specific transporters in crypt apical membranes (41) . Using these experimental approaches, we have studied HCO 3 Ϫ secretion in isolated microperfused crypts from the rat distal colon (25) . In these studies, neither endogenous nor Cl Ϫ -dependent HCO 3 Ϫ secretion was identified, but vasoactive intestinal peptide (VIP), acetyl choline, and dibutyryl cAMP induced HCO 3 Ϫ secretion that required HCO 3 Ϫ in the serosal bath. This HCO 3 Ϫ secretion was not altered by the removal of lumen Cl Ϫ but was inhibited by lumen 5-nitro-3-(3-phenylpropyl-amino)benzoic acid (NPPB), a nonspecific Cl Ϫ channel blocker (25) . Because these studies were performed in isolated crypts, it is not known whether cAMPinduced HCO 3 Ϫ secretion also occurs in surface cells and, if it does, whether the mechanism of HCO 3 Ϫ secretion in surface cells is similar to or different from that in crypt cells.
Short-chain fatty acids (SCFA) are the major anions in stool but are not present in the diet (8) . SCFA are produced by fermentation of nonabsorbed carbohydrate by colonic bacteria. The primary SCFA are acetate, propionate, and butyrate, with butyrate being the primary nutrient for colonocytes (43) . In addition to SCFA stimulation of fluid, Na ϩ , and Cl Ϫ absorption, SCFA also induce HCO 3 Ϫ secretion (62) . The model of butyrate stimulation of Na ϩ and Cl Ϫ absorption is based on butyrate uptake across the apical membrane via a butyrate/ HCO 3 Ϫ exchange (or via nonionic diffusion) linked to apical membrane Na ϩ /H ϩ and Cl Ϫ /butyrate exchanges (4, 11, 32, 39) . Detailed information regarding the mechanism of SCFAinduced HCO 3 Ϫ secretion is limited. The present study was initiated to examine HCO 3 Ϫ secretion in isolated intact colonic mucosa with the use of pH stat methods to provide quantitation of HCO 3 Ϫ secretion. The pH stat method with intact colonic mucosa identifies HCO 3 Ϫ se-cretion that may originate in surface or crypt cells. If the characteristics of HCO 3 Ϫ secretion were found to differ qualitatively from those previously described in isolated crypts, we would conclude that different mechanisms of HCO 3 Ϫ secretion exist in surface and crypt cells. In contrast, if the characteristics of HCO 3 Ϫ secretion in the present studies with the use of pH stat methods were identical to those observed in isolated perfused crypts, it would be uncertain whether HCO 3 Ϫ secretion is present in surface cells as well as in crypt cells. We report the identification, characterization, and interrelationship of three distinct modes of HCO 3 Ϫ secretion: Cl Ϫ dependent, cAMP stimulated, and SCFA dependent.
METHODS
Nonfasting male Sprague-Dawley rats weighing 200 -250 g were used in all experiments. Colonic mucosa was obtained from the distal colon after exsanguination, and HCO 3 Ϫ transport studies were performed in mucosa that was stripped of muscular and submucosal layers as described by Fromm et al. (23) . Mucosa was mounted between Ussing-type Lucite chambers as previously described (6) . All experiments were approved by the Yale University Institutional Animal Care and Use Committee.
pH stat recordings. HCO 3 Ϫ secretion was quantitated with the use of Bi-burette TIM 856 (Radiometer Analytical, Villeurbanne, France), which titrates both above and below stat pH 7.4 with a hysteresis of 0.05 and thus titrates between pH 7.35 and 7.45 (i.e., the physiological limits of pH range for bodily fluids). With the use of this technique, the lumen solution pH was continuously maintained at a constant (or stat) pH by the addition of 0.025 N H 2SO4. Pumps were programmed to operate in real time according to the pH changes of the lumen solution, with the pumps calibrated to deliver a minimum of 0.05 l at a given time. Calibration of standard to stat pH was established by adding increasing concentrations of acid. A known quantity of H 2SO4 added to a minimally buffered solution titrated against HCO 3 Ϫ provided a linear curve. The amount of HCO 3 Ϫ measured in the lumen solution was always within the linear range of this curve. The acid used for the titration was diluted in the same ionic solution as that used in that particular experiment to obtain a final concentration of 0.025 M. Colonic tissues were always exposed to a buffered solution on the bath side, while tissues on the lumen side were exposed to a minimally buffered solution (0.1 mM HEPES buffer, pH 7.4) (46) . HCO 3 Ϫ secretion is equivalent to the amount of acid required to maintain pH 7.4. All experiments were performed under voltageclamp conditions, and HCO 3 Ϫ -free solutions were gassed with 100% O2, while HCO 3 Ϫ -containing solutions were gassed with 95% O2-5% CO2. HCO 3 Ϫ secretion was expressed as microequivalents per hour per square centimeter.
Initial studies demonstrated that immediately after the tissue was mounted, HCO 3 Ϫ secretion was present in the absence of bath HCO 3 Ϫ but rapidly fell toward 0 within 20 -30 min. If bath HCO 3 Ϫ was not added, HCO 3 Ϫ secretion remained close to 0. Addition of HCO 3 Ϫ to bath solution resulted in a rapid increase in HCO 3 Ϫ secretion that remained constant for Ն60 min (Fig. 1) . All experiments were performed during this 1-h steady-state period.
In experiments in which inhibitors were added to the mucosal solution, the specific drug was added during the initial steady-state period, pH was adjusted, and tissue was allowed to equilibrate for 30 min until a steady rate of HCO 3 Ϫ secretion was again observed. In experiments in which the inhibitor was added to the serosal side, the tissue was also equilibrated for 30 min to achieve a steady state of HCO 3 Ϫ secretion. In experiments in which isobutyrate was used, 25 mM isobutyrate solution was first neutralized with N-methyl-D-glucamine (NMDG) before use. The composition of the several solutions used in these experiments is presented in Table 1 . In brief, in Cl Ϫ -free experiments, isethionate was used as a substitute for Cl Ϫ ; in Na ϩ -free experiments, NMDG was used as a Na ϩ substitute. Glucose (10 mM) was added to all solutions. Only one tissue from each animal was used for a specific experiment, and only one experimental condition was used with each tissue. All experiments were repeated at least four times.
Ion flux studies. Unidirectional Na ϩ and Cl Ϫ fluxes were performed across isolated colonic mucosa with 22 Na and 36 Cl under short-circuit conditions (DVC 1000; World Precision Instruments, Sarasota, FL) as previously described (3, 6) . Tissues were paired on the basis of a conductance difference of Ͻ10%. Net ion fluxes (J net) were then calculated from the difference between mucosal-to-serosal transport (J ms) and serosal-to-mucosal transport (Jsm). Positive values reflect net absorption, and negative values reflect net secretion. Samples were collected from the cold side after a 15-min equilibration period and thereafter at 15-min intervals for three time periods.
Statistics. Results are presented as means Ϯ SE. Statistical analyses were performed with the use of paired and unpaired t-tests and Bonferroni's one-way ANOVA post hoc test. P Ͻ 0.05 was considered significant.
Chemicals and solutions. Amiloride, 8-bromo-cAMP, 4,4Ј-diisothiocyanostilbene-2,2Ј-disulfonic acid (DIDS), dimethyl sulfoxide grade I, glibenclamide, N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid (HEPES), isethionic acid, NMDG, NPPB, potassium gluconate, and sodium gluconate were obtained from Sigma. 36 Cl and 22 Na were obtained from Amersham Biosciences (Piscataway, NJ).
RESULTS

Cl
Ϫ -dependent HCO 3 Ϫ secretion. The initial experiment was performed to determine whether there was endogenous secretion of HCO 3 Ϫ , i.e., in the presence of a nominally HCO 3 Ϫ -free solution in the serosal or bath solution of rat distal colon. Under conditions in which the colonic mucosa was bathed on both the lumen and bath sides with a nominally HCO 3 Ϫ -free Ringer solution, only a minimal rate of HCO 3 Ϫ secretion was observed (0.3 Ϯ 0.03 eq ⅐ h Ϫ1 ⅐ cm Ϫ2 ) in the presence of lumen Cl Ϫ . Ϫ secretion was defined as the amount of H2SO4 required to maintain pH at a fixed or stat pH (7.4) and expressed as eq ⅐ h Ϫ1 ⅐ cm
Ϫ2
. HCO 3 Ϫ secretion was linear within 20 min of the addition of bath HCO 3 Ϫ and lasted for Ն60 -100 min.
The addition of HCO 3 Ϫ to the bath solution resulted in a substantial rate of HCO 3 Ϫ secretion (5.7 Ϯ 0.04 eq⅐h Ϫ1 ⅐cm Ϫ2 ), indicating that basal HCO 3 Ϫ secretion required bath HCO 3 Ϫ (Fig. 2 ). Because the methodology of these pH stat studies requires an unbuffered or minimally buffered lumen solution (i.e., one that is nominally HCO 3 Ϫ -free), experiments could not be performed to assess whether the presence of HCO 3 Ϫ in the lumen solution modified HCO 3 Ϫ secretion. To establish that the observed rate of HCO 3 Ϫ secretion was not masking the actual rate of basal secretion as a result of its partial neutralization by simultaneous proton secretion, e.g., K ϩ /H ϩ exchange, experiments were performed in which potential proton secretion into the lumen solution was inhibited. Table 2 demonstrates that in the presence of 1 mM orthovanadate, an inhibitor of P-type ATPases, HCO 3 Ϫ secretion was significantly increased by ϳ7%, suggesting that HCO 3 Ϫ secretion was only minimally reduced by parallel K
Ϫ secretion was also measured in experiments in which apical membrane Na ϩ /H ϩ exchange was inhibited by the removal of lumen Na ϩ , by the addition of 1 mM amiloride to the lumen solution, and by both the removal of lumen Na ϩ and the addition of amiloride. Inhibition of Na ϩ /H ϩ exchange in each of these three experimental conditions resulted in a minimal though significant decrease in the rate of HCO 3 Ϫ secretion ( Table 2) . As a result, the observed HCO 3 Ϫ secretion represented net HCO 3
To determine whether basal HCO 3 Ϫ secretion was Cl Ϫ dependent, we measured HCO 3 Ϫ secretion in the absence of lumen Cl Ϫ . As shown in Fig. 3 , the absence of Cl Ϫ from the lumen solution resulted in almost complete elimination of basal HCO 3 Ϫ secretion (0.6 Ϯ 0.02 eq⅐h Ϫ1 ⅐cm Ϫ2 ), indicating that basal HCO 3 Ϫ secretion was lumen Cl Ϫ dependent. Thus basal HCO 3 Ϫ secretion is completely dependent on lumen Cl Ϫ and as a result is referred to as Cl Ϫ -dependent HCO 3 Ϫ secretion. To establish whether Cl Ϫ -dependent HCO 3 Ϫ secretion involves an apical membrane Cl Ϫ /HCO 3 Ϫ exchange, we performed experiments with an anion exchange inhibitor, DIDS (100 M). DIDS, which at 100 M concentration is an inhibitor of Cl Ϫ /anion exchanges (40, 57) , completely inhibited HCO 3 Ϫ secretion (0.5 Ϯ 0.04 eq⅐h Ϫ1 ⅐cm Ϫ2 ), which is consistent with a Cl Ϫ /HCO 3 Ϫ exchange being closely associated with HCO 3 Ϫ movement across the apical membrane ( Fig.  3 ). Experiments were also performed to assess the effect of acetazolamide, a carbonic anhydrase (CA) inhibitor, on Cl experiments were performed to determine whether an apical membrane Cl Ϫ /HCO 3 Ϫ exchange is a carrier-mediated process, by assessing its kinetic characteristics. Increasing concentrations of lumen Cl Ϫ resulted in an enhanced but saturable rate of HCO 3 Ϫ secretion with evidence of saturation kinetics (Fig.  4) . These experiments yielded a K m for Cl Ϫ of 1.0 Ϯ 0.03 mM and a V max of 5.6 Ϯ 0.03 eq⅐h Ϫ1 ⅐cm
. Because VIP-stimulated HCO 3 Ϫ secretion in studies performed with isolated colonic crypts was inhibited by NPPB, a nonspecific Cl Ϫ channel blocker (24, 57) , the effect of NPPB on Cl Ϫ -dependent HCO 3 Ϫ secretion was also determined. (Fig. 3) 3 Ϫ secretion in the present studies with isolated intact colonic mucosa that included both surface and crypt cells. Therefore, the effect of 8-bromo-cAMP on HCO 3 Ϫ secretion was characterized. As shown in Fig. 5 , in the absence of lumen Cl Ϫ , HCO 3 Ϫ secretion was minimal, but the addition of 0.5 mM 8-bromo-cAMP resulted in a marked increase in HCO 3 Ϫ secretion. To determine whether cAMP-stimulated HCO 3 Ϫ secretion required bath HCO 3 Ϫ , as was demonstrated for Cl Ϫ -dependent HCO 3 Ϫ secretion (Fig. 2) , the rate of HCO 3 Ϫ secretion in the presence of 8-bromo-cAMP was established in the absence of bath HCO 3 Ϫ . Figure 5 demonstrates that cAMP-stimulated HCO 3 Ϫ secretion was markedly inhibited by the removal of bath HCO 3 Ϫ . To assess whether cAMP-stimulated HCO 3 Ϫ secretion was associated with an apical membrane anion channel, we also examined the effect of NPPB, a nonspecific Cl Ϫ channel Ϫ secretion also was measured in the presence of 3 transport inhibitors (crosshatched bars): 100 M DIDS, 100 M acetazolamide (ACZ), and 100 M 5-nitro-3-(3-phenylpropyl-amino)benzoic acid (NPPB). Numbers in parentheses indicate number of tissues studied in each group. *P Ͻ 0.001 compared with group without lumen Cl Ϫ . **P Ͻ 0.001 compared with lumen Cl Ϫ group without any transport inhibitors. ϩNot significantly different from lumen Cl Ϫ group without any transport inhibitors. Mucosa from the distal colon was studied in HCO 3 Ϫ -containing Ringer solution on the bath side and HCO 3 Ϫ -free unbuffered solution on the lumen side. Results are presented as means Ϯ SE and represent the mean of three 15-min flux periods. Six tissues were studied in each unidirectional flux group. Net flux (Jnet) represents the difference between mucosal-to-serosal transport (Jms) and serosal-to-mucosal transport (Jsm). Fluxes are expressed as eq ⅐ h Ϫ1 ⅐ cm Ϫ2 . Mean conductance for these tissues was 6.1 Ϯ 0.4 mS/cm 2 .
blocker. Figure 6 demonstrates that HCO 3 Ϫ secretion in the presence of 8-bromo-cAMP was completely inhibited by 100 M NPPB (0.5 Ϯ 0.03 eq⅐h Ϫ1 ⅐cm Ϫ2 ), indicating that cAMP mediates HCO 3 Ϫ secretion via apical membrane anion channels. Because NPPB at 100 M concentration is a nonspecific Cl Ϫ channel blocker (24, 57) , studies were also performed with 300 M glibenclamide, a concentration at which glibenclamide is a relatively specific inhibitor of CFTR, and with 1 mM DIDS, a concentration at which DIDS inhibits the outwardly directed Cl Ϫ conductance. Figure 6 demonstrates that cAMP-stimulated HCO 3 Ϫ secretion was completely inhibited by 300 M glibenclamide but was not altered by 1 mM DIDS (4.9 Ϯ 0.08 eq⅐h Ϫ1 ⅐cm Ϫ2 ), suggesting a role for CFTR in cAMP-induced HCO 3 Ϫ secretion. To exclude an effect of glibenclamide on apical membrane K ϩ channels, the addition of 5 mM barium to the luminal solution was evaluated, but it did not affect HCO 3 Ϫ secretion (data not shown). Parallel studies performed in the presence of lumen Cl Ϫ provided an opportunity to determine whether cAMP also modifies Cl Ϫ -dependent HCO 3 Ϫ secretion. cAMP-stimulated HCO 3 Ϫ secretion was not altered by the removal of lumen Cl Ϫ (4.9 Ϯ 0.09 vs. 5.1 Ϯ 0.01 eq⅐h Ϫ1 ⅐cm Ϫ2 ), indicating that cAMP-stimulated HCO 3 Ϫ secretion was Cl Ϫ independent and suggesting that cAMP inhibited Cl Ϫ -dependent HCO 3 Ϫ secretion. Additional experiments were performed with anion transport inhibitors to confirm that cAMP modified Cl Ϫ -dependent HCO 3 Ϫ secretion. Figure 7 demonstrates that NPPB inhibited HCO 3 Ϫ secretion to a rate identical to that observed in the absence of lumen Cl Ϫ (0.5 Ϯ 0.03 vs. 0.4 Ϯ 0.04 eq⅐h Ϫ1 ⅐cm Ϫ2 ). In contrast, 100 M DIDS did not inhibit cAMP-stimulated HCO 3 Ϫ secretion. Although acetazolamide markedly inhibited Cl Ϫ -dependent HCO 3 Ϫ secretion (Fig. 3) , cAMP-induced HCO 3 Ϫ secretion in the presence of lumen Cl Ϫ was only minimally reduced by acetazolamide (Fig. 7) . These results provide compelling evidence that Cl Ϫ -dependent HCO 3 Ϫ secretion is absent in the presence of cAMP. Thus cAMP both induced Cl Ϫ -independent HCO 3 Ϫ secretion via an anion channel and inhibited Cl Ϫ -dependent HCO 3 Ϫ secretion. SCFA-dependent HCO 3 Ϫ secretion. In vivo studies of HCO 3 Ϫ secretion previously demonstrated that SCFA increases HCO 3 Ϫ secretion but did not establish the mechanism of its effects (62) . To assess the effect of the transport of a SCFA rather than its metabolism, we performed these SCFA studies with isobutyrate, a poorly metabolized SCFA. In another series of studies, 25 mM isobutyrate was added to a luminal Cl Ϫ -free solution, and both the rate and the characteristics of HCO 3 Ϫ secretion were determined. The addition of 25 mM isobutyrate significantly enhanced HCO 3 Ϫ secretion to 5.7 Ϯ 0.05 eq⅐h Ϫ1 ⅐cm Ϫ2 (Table 4) , a rate that is identical to that of Cl Ϫ -dependent HCO 3 Ϫ secretion (Fig. 3) . Isobutyrate-dependent HCO 3 Ϫ secre- Fig. 5 . Effect of cAMP and bath HCO 3 Ϫ on Cl Ϫ -independent HCO 3 Ϫ secretion. HCO 3 Ϫ secretion was determined in the absence or presence of 8-bromo-cAMP and/or bath HCO 3 Ϫ as indicated. Numbers in parentheses indicate number of tissues studied in each group. *P Ͻ 0.001 compared with group without cAMP. **P Ͻ 0.001 compared with cAMP, bath HCO 3 Ϫ group.
Fig. 6. Effect of anion channel blockers on cAMP-induced HCO 3
Ϫ secretion in the absence of lumen Cl Ϫ . HCO 3 Ϫ secretion was measured in presence of 8-bromo-cAMP (hatched bar; control). cAMP-stimulated HCO 3 Ϫ secretion was also measured in the presence of 3 channel blockers (crosshatched bars): 100 M NPPB, 300 M glibenclamide (Glib), and 1 mM DIDS. Numbers in parentheses indicate number of tissues studied in each group. *Not significantly different from control group; **P Ͻ 0.001 compared with control group.
Fig. 7. Effect of anion transport inhibitors on HCO 3
Ϫ secretion in the presence of lumen Cl Ϫ and 8-bromo-cAMP. 8-bromo-cAMP-stimulated HCO 3 Ϫ secretion was measured in the presence of lumen Cl Ϫ (hatched bar; control). Anion transport inhibitors were used to characterize cAMP-stimulated HCO 3 Ϫ secretion (crosshatched bars): 100 M NPPB, 1 mM DIDS, and 100 M ACZ. Numbers in parentheses indicate number of tissues studied in each group. *P Ͻ 0.001 compared with control group. **Not significantly different from control group. ϩP Ͻ 0.01 compared with control group. tion was also determined in the absence of bath HCO 3 Ϫ . Isobutyrate-dependent HCO 3 Ϫ secretion was substantially reduced by the removal of bath HCO 3 Ϫ (0.5 Ϯ 0.03 vs. 5.6 Ϯ 0.03 eq⅐h Ϫ1 ⅐cm Ϫ2 ), and this rate was similar to the rate of Cl Ϫ -dependent HCO 3 Ϫ secretion in the absence of bath HCO 3 Ϫ . These observations exclude the possibility that the observed luminal alkalinization that we proposed represented HCO 3 Ϫ secretion was due to either H ϩ -SCFA cotransport or nonionic diffusion.
Because the rate of isobutyrate-dependent HCO 3 Ϫ secretion (in the absence of lumen Cl Ϫ ) was similar to that of Cl Ϫ -dependent HCO 3 Ϫ secretion ( 3 Ϫ secretion in the presence of both isobutyrate and lumen Cl Ϫ was not substantially altered by either DIDS or acetazolamide. To exclude the possibility that isobutyrate induced HCO 3 Ϫ secretion that was mediated by anion channels, we also examined the effect of NPPB. NPPB (100 M) did not affect HCO 3 Ϫ secretion in the presence of isobutyrate and lumen Cl Ϫ . These results establish that in the presence of both isobutyrate and Cl Ϫ , HCO 3 Ϫ secretion is insensitive to DIDS, acetazolamide, and NPPB, and thus isobutyrate both stimulated Cl Ϫ -independent HCO 3 Ϫ secretion and inhibited Cl Ϫ -dependent HCO 3 Ϫ secretion. To characterize further SCFA-dependent HCO 3 Ϫ secretion, we performed kinetic experiments. Figure 8 demonstrates that increasing concentrations of isobutyrate in the absence of lumen Cl Ϫ resulted in an enhanced rate of HCO 3 Ϫ secretion with evidence of saturation kinetics with a kinetic constant K m for isobutyrate of 2.9 Ϯ 0.14 mM and a V max of 5.9 Ϯ 0.08 eq⅐h Ϫ1 ⅐cm Ϫ2 . These results permit the conclusion that isobutyrate-dependent HCO 3 Ϫ secretion is mediated by an apical membrane NPPB-insensitive, DIDS-insensitive, Cl Ϫ -independent, carrier-mediated transport mechanism. Thus isobutyratedependent HCO 3 Ϫ secretion is likely secondary to apical membrane SCFA/HCO 3 Ϫ exchange. Because the data presented in Table 4 indicate that Cl Ϫ -dependent HCO 3 Ϫ secretion was inhibited by isobutyrate, a final series of experiments were designed to assess the effect of isobutyrate on cAMP-stimulated HCO 3 Ϫ secretion. Figure 6 shows that in the absence of isobutyrate, cAMP-induced HCO 3 Ϫ secretion was NPPB sensitive. When isobutyrate was present together with cAMP, HCO 3 Ϫ secretion was not altered by NPPB (5.7 Ϯ 0.05 vs. 5.7 Ϯ 0.07 eq⅐h Ϫ1 ⅐cm Ϫ2 ). Because these experiments were performed in the absence of lumen Cl Ϫ , HCO 3 Ϫ secretion was Cl Ϫ independent and NPPB insensitive. These characteristics are those of SCFA-dependent HCO 3 Ϫ secretion and not those of cAMP-stimulated HCO 3 Ϫ secretion, suggesting that isobutyrate also inhibited cAMPstimulated HCO 3 Ϫ secretion.
DISCUSSION
HCO 3
Ϫ secretion is an important component of normal colonic fluid and electrolyte movement and is a major fraction of the fluid secreted in several diarrheal diseases (21) . Despite the essential role of HCO 3 Ϫ secretion both in health and in diarrhea, the mechanism of HCO 3 Ϫ movement in general and HCO 3 Ϫ secretion in particular in both the small and large intestines has been studied relatively infrequently, especially compared with Ϫ , e.g., the inability to use isotopes to measure HCO 3 Ϫ flux at pH 7.4. 2) HCO 3 Ϫ secretion has often been studied in in vitro studies by determining so-called residual flux (J r ), i.e., the portion of the short-circuit current that is not accounted for by measured Na ϩ , Cl Ϫ , and K ϩ fluxes (18) . The use of J r to determine HCO 3 Ϫ movement is indirect and is subject to significant experimental variability. 3) HCO 3 Ϫ secretion, when estimated from J r , can be highly variable in in vitro experiments and is often substantially less than that observed in in vivo studies. An adequate explanation for the lower rates of HCO 3 Ϫ secretion observed in in vitro studies compared with those observed in in vivo studies has not been identified.
Several investigators have used an alternate experimental approach, pH stat, to determine HCO 3 Ϫ movement in vitro in several intestinal epithelia (13, 19, 20, 26, 33, 45, 46, 48, 52) . In this method, low concentrations of acid are added to maintain the mucosal solution at a fixed pH (i.e., 7.4). HCO 3 Ϫ secretion is assumed to be equivalent to the amount of acid added to maintain the designated stat pH. This general approach has been used to determine HCO 3 Ϫ movement in gastric, duodenal, ileal, and colonic mucosa (13, 19, 20, 26, 33, 45, 46, 48, 52, 56) . We adapted this methodology to study HCO 3 Ϫ secretion in the rat distal colon to complement prior studies of HCO 3 Ϫ secretion in isolated colonic crypt glands (25) . HCO 3 Ϫ secretion determined with this approach could theoretically be underestimated if there were also simultaneous proton secretion. In the present experiments, proton secretion resulted in Ͻ10% underestimation of HCO 3 Ϫ secretion, as inhibition of H ϩ -K ϩ -ATPase resulted in only a minimal but significant increase in HCO 3 Ϫ secretion ( Table 2 ). The model of NaCl absorption in the rat distal colon that has been developed during the past 20 years is the presence in the apical membrane of parallel ion exchangers, Na ϩ /H ϩ exchange and Cl Ϫ /HCO 3 Ϫ exchange, coupled with intracellular pH (pH i ) (7) . The relationship between Cl Ϫ /HCO 3 Ϫ exchange and Na ϩ /H ϩ exchange in the rat distal colon is complex. Ion fluxes performed under voltage-clamp conditions in the absence of ion gradients have generally revealed approximately equal rates of net Na ϩ and net Cl Ϫ absorption (3, 4, 7) , and inhibition of Na ϩ /H ϩ exchange by 1 mM amiloride decreases net Cl Ϫ absorption (3, 35) . Coupling of these two ion exchanges has been demonstrated in studies with brush-border vesicles prepared from rabbit ileum as well as in luminal perfusion experiments in human ileum and rat colon (30, 37, 60) . Nonetheless, both exchanges are functionally independent of Cl Ϫ and Na ϩ , because ion uptake studies with the use of AMV prepared from rat distal colon have demonstrated Na ϩ /H ϩ exchange and Cl Ϫ /HCO 3 Ϫ exchange activities that are independent of Cl Ϫ and Na ϩ , respectively (40, 42) . Furthermore, in the proximal small intestine, HCO 3 Ϫ absorption is a result of an apical membrane Na ϩ /H ϩ exchange that is present in the absence of an anion exchanger (61) , while in the colon, when the rate of Cl Ϫ / HCO 3 Ϫ exchange is greater than that of Na ϩ /H ϩ exchange, both Cl Ϫ -dependent HCO 3 Ϫ secretion and net NaCl absorption have been observed (17) .
The present studies demonstrate Cl Ϫ -dependent HCO 3 Ϫ secretion with the use of pH stat methodology that requires that either no buffer or a very low buffering capacity be present in the lumen solution. Table 2 demonstrates that the removal of lumen Na ϩ and/or the addition of 1 mM amiloride to the lumen solution did not increase HCO 3 Ϫ secretion. The failure to observe an enhancement in HCO 3 Ϫ secretion after inhibition of apical membrane Na ϩ /H ϩ exchange may be a result of the fact that in the presence of bath-to-lumen HCO 3 Ϫ gradient, an apical membrane Na ϩ /H ϩ exchange is absent. To address this possibility, we measured Na ϩ and Cl Ϫ isotopic flux under the identical experimental conditions that were used in the HCO 3 Ϫ secretion studies, i.e., the presence of a bath-to-lumen HCO 3 Ϫ gradient (Table 3) . These studies demonstrated an absence of net Na ϩ absorption and a rate of net Cl Ϫ absorption that was approximately equal to that of HCO 3 Ϫ secretion determined in the pH stat studies (5.1 Ϯ 0.2 vs. 5.7 Ϯ 0.04 eq⅐h Ϫ1 ⅐cm Ϫ2 ). The rate of net Cl Ϫ absorption in the present experiments is approximately equal to that observed in several prior studies of Cl Ϫ movement across the rat distal colon (3, 4, 7, 58) . These experiments provide compelling evidence that the presence of a HCO 3 Ϫ gradient results in inhibition of net Na ϩ absorption and explains the failure to observe an increase in Cl Ϫ -dependent HCO 3 Ϫ secretion after experimental maneuvers to inhibit apical membrane Na ϩ /H ϩ exchange (Table 3) . One possible explanation for this observation is that HCO 3 Ϫ movement from bath to cell (in the absence of adequate luminal buffering) raises pH i , thus reducing the driving force for Na ϩ /H ϩ exchange. Future studies of pH i in surface cells of rat distal colon are required to explore these relationships.
Investigation of colonic HCO 3 Ϫ secretion has been undertaken in several species, including humans, during the past 50 years (14, 15, 17, 19, 20, 25, 38, 52) . Most of these in vivo studies have used a luminal perfusion methodology and have largely made similar observations: HCO 3 Ϫ secretion appears to be an active transport process as luminal concentrations of HCO 3 Ϫ increase above plasma concentrations, and the electrical potential difference is lumen negative (14, 15, 17, 38) . In general, HCO 3 Ϫ secretion has been established as lumen Cl Ϫ dependent and is attributed to an apical membrane Cl Ϫ /HCO 3 Ϫ exchange. Evidence in support of an apical membrane Cl Ϫ / HCO 3 Ϫ exchange as the mechanism of colonic HCO 3 Ϫ secretion has also been provided by observations in congenital chloridorrhea, a diarrheal disorder associated with high stool Cl Ϫ concentrations (27, 36) . Luminal perfusion studies in these patients established the absence of Cl Ϫ -dependent HCO 3 Ϫ exchange in the ileum and the colon (but not in the jejunum) (2, 59) , and mutations in the DRA (downregulated in adenoma) gene have been identified as the cause of congenital chloridorrhea (34, 36) . Furthermore, DRA has been identified as an anion transporter (47 (17) . Several specific models of HCO 3 Ϫ secretion have been identified in different epithelia (13, 17, 28, 29, 49, 53, 55) . The source of HCO 3 Ϫ can be either endogenous synthesis from CO 2 and H 2 O by enzymatic action of CA or bath HCO 3 Ϫ with transport across the basolateral membrane. In human and bovine airway cells, HCO 3 Ϫ secretion is linked to endogenous CO 2 production with HCO 3 Ϫ movement across the apical mem-brane and proton movement across the basolateral membrane via Na/H exchange (49) . HCO 3 Ϫ secretion that is linked to endogenous CO 2 production has been reduced by inhibition of CA (38) (Fig. 3) , acetazolamide did not inhibit or only minimally inhibited cAMP-induced and SCFA-dependent HCO 3 Ϫ secretion, respectively ( Fig. 7 and Table 4 ), which indicates that apical membrane anion channel and SCFA/ HCO 3 Ϫ exchange are not coupled to CA-II. Although the molecular identity of SCFA/HCO 3 Ϫ exchange is not known, these results permit the speculation that neither AE1 nor DRA encodes the SCFA/HCO 3 Ϫ exchange protein. The paradigm of colonic ion function is presently a separation of crypt cell and surface cell function (63) . Absorptive processes are largely confined to surface cells, while secretory processes are localized in crypt cells. HCO 3 Ϫ secretion has been studied successfully in isolated colonic crypts, and those studies failed to identify basal or Cl Ϫ -dependent HCO 3 Ϫ secretion (25) . This observation is consistent with the localization of Cl Ϫ /HCO 3 Ϫ exchange to apical membranes of surface cells but not to those of crypt cells (40) . Furthermore, the finding of Cl Ϫ -independent HCO 3 Ϫ secretion in the crypt contrasts with in vitro experiments with intact mucosa in which HCO 3 Ϫ secretion was identified as Cl Ϫ dependent. These observations indicate that Cl Ϫ -dependent HCO 3 Ϫ secretion is a surface cell function, while Cl Ϫ -independent secretion is most likely a crypt cell function. cAMP stimulated HCO 3 Ϫ secretion both in isolated crypts (25) and in the present studies with intact mucosa that included both surface and crypt cells. HCO 3 Ϫ secretion as determined in these pH stat studies could represent HCO 3 Ϫ that was secreted from crypt and/or surface cells. Because cAMP-stimulated Cl Ϫ secretion is most likely predominantly restricted to crypt cells (1), cAMP-stimulated HCO 3 Ϫ secretion might also be an exclusive crypt cell function. However, it is not known whether HCO 3 Ϫ secretion is also generated from surface cells, because intact mucosa containing both surface and crypt cells was used in the present studies. Such a conclusion requires the study of surface cells independently of crypt cells.
Besides the induction of HCO 3 Ϫ secretion in colonic crypts and possibly in colonic surface cells, cAMP has several other effects on colonic ion transport (1, 3, 22) . cAMP stimulates both active Cl Ϫ secretion and active K ϩ secretion (1, 22) . Electroneutral NaCl absorption is also inhibited by increased intramucosal concentrations of cAMP (3); the reduction of electroneutral NaCl absorption is most likely a result of its inhibition of Na ϩ /H ϩ exchange and/or Cl Ϫ /HCO 3 Ϫ exchange.
In the present studies, cAMP not only stimulated HCO 3 Ϫ secretion but also was associated with downregulation of Cl Ϫ -dependent HCO 3 Ϫ secretion, which most likely was a result of cAMP inhibition of apical membrane Cl Ϫ /HCO 3 Ϫ exchange (Fig. 7) . Although in intact mucosa cAMP appears to completely inhibit apical DIDS-sensitive, Cl Ϫ -dependent HCO 3 Ϫ secretion, cAMP has not been reported to inhibit the Cl Ϫ /HCO 3 Ϫ exchange activity of either DIDS-sensitive AE1 or relatively DIDS-insensitive DRA when they are expressed in the in vitro recombinant expression system (12) . The possibility that cAMP-stimulated HCO 3 Ϫ secretion represented the coupling of an apical membrane Cl Ϫ /HCO 3 Ϫ exchange to CFTR was also excluded by demonstrating that the removal of lumen Cl Ϫ did not affect cAMP-induced HCO 3 Ϫ secretion in either the absence (3.4 Ϯ 0.05 vs. 3.6 Ϯ 0.09 eq⅐h Ϫ1 ⅐cm Ϫ2 ) or presence (4.8 Ϯ 0.02 vs. 5.2 Ϯ eq⅐h Ϫ1 ⅐cm
Ϫ2
) of bath Cl Ϫ . This indicates that cAMP-stimulated HCO 3 Ϫ secretion was a result of an apical membrane anion channel and was not due to the coupling of a Cl Ϫ /HCO 3 Ϫ exchange to an apical membrane anion channel (Figs. 6 and 7) .
The mechanism of the uptake of SCFA across the apical membrane of colonocytes has been controversial, with evidence of both an apical membrane butyrate/HCO 3 Ϫ exchange and nonionic diffusion (11, 32) . It is not unlikely that both mechanisms are operative, with their relative contribution to overall SCFA uptake varying as a function of species and one or more experimental conditions. Several in vivo studies that have observed HCO 3 Ϫ secretion in association with butyrate absorption support the possibility that butyrate uptake across the apical membrane occurs via a SCFA/HCO 3 Ϫ exchange. Table 4 demonstrates that isobutyrate stimulates Cl Ϫ -independent HCO 3 Ϫ secretion that is insensitive to both DIDS and NPPB. The presence of saturation kinetics (Fig. 8) provides compelling support for a carrier-mediated exchange process Fig. 9 . Cellular model of HCO 3 Ϫ secretion in colonocytes of rat distal colon. Three distinct modes of HCO 3 Ϫ secretion were identified in rat distal colon: 1) Cl Ϫ -dependent HCO 3 Ϫ secretion is mediated by apical membrane Cl Ϫ /HCO 3 Ϫ exchange; the specific apical membrane protein responsible for Cl Ϫ /HCO 3 Ϫ exchange is uncertain, is indicated as AE? (anion exchange), and could represent either AE1 or DRA (downregulated in adenoma. 2) SCFA-dependent HCO 3 Ϫ secretion is mediated by apical membrane SCFA-HCO 3 Ϫ exchange whose molecular identity has not been established. 3) cAMP-stimulated HCO 3 Ϫ secretion is mediated by apical membrane CFTR. cAMP also inhibited Cl Ϫ -dependent HCO 3 Ϫ secretion, while SCFA downregulated both Cl Ϫ -dependent HCO 3 Ϫ secretion and cAMP-induced HCO 3 Ϫ secretion.
